γ -干扰素在癌症治疗中的应用。

Molecular biotherapy Pub Date : 1991-12-01

L M Weiner

{"title":"γ -干扰素在癌症治疗中的应用。","authors":"L M Weiner","doi":"","DOIUrl":null,"url":null,"abstract":"This review focuses on the use of gamma-interferon (gamma-IFN) in cancer therapy. Although clinical trials using gamma-IFN have yet to identify a treatment niche for this cytokine, these studies have led to a greater understanding of the pleiotropic effects of this molecule on the human immune response, as well as identification of the dose range required for optimal biologic response modification. Thus, continued efforts to clinically develop gamma-IFN are warranted.","PeriodicalId":18809,"journal":{"name":"Molecular biotherapy","volume":"3 4","pages":"186-91"},"PeriodicalIF":0.0000,"publicationDate":"1991-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Applications of gamma-interferon in cancer therapy.\",\"authors\":\"L M Weiner\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This review focuses on the use of gamma-interferon (gamma-IFN) in cancer therapy. Although clinical trials using gamma-IFN have yet to identify a treatment niche for this cytokine, these studies have led to a greater understanding of the pleiotropic effects of this molecule on the human immune response, as well as identification of the dose range required for optimal biologic response modification. Thus, continued efforts to clinically develop gamma-IFN are warranted.\",\"PeriodicalId\":18809,\"journal\":{\"name\":\"Molecular biotherapy\",\"volume\":\"3 4\",\"pages\":\"186-91\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1991-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular biotherapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular biotherapy","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

本文综述了γ -干扰素(γ - ifn)在癌症治疗中的应用。尽管使用γ - ifn的临床试验尚未确定这种细胞因子的治疗利基，但这些研究已经使人们对这种分子对人体免疫反应的多效作用有了更深入的了解，并确定了最佳生物反应修饰所需的剂量范围。因此，继续努力临床开发γ - ifn是必要的。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

Applications of gamma-interferon in cancer therapy.

This review focuses on the use of gamma-interferon (gamma-IFN) in cancer therapy. Although clinical trials using gamma-IFN have yet to identify a treatment niche for this cytokine, these studies have led to a greater understanding of the pleiotropic effects of this molecule on the human immune response, as well as identification of the dose range required for optimal biologic response modification. Thus, continued efforts to clinically develop gamma-IFN are warranted.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Molecular biotherapy

自引率

0.00%

发文量